Structure-activity relationships of some alkylated iminosugars Nikolay Kukushkin, St.-Petersburg State University
Iminosugar Ceramide-specific glucosyltransferase α -glucosidases I & II Glucose NB-DNJ
Ceramide-specific glucosyltransferase Biosynthesis Catabolism GSL pool Treatment of glycosphingolipid (GSL) storage diseases
Ceramide-specific glucosyltransferase Key enzyme in GSL biosynthesis Key enzyme in GSL biosynthesis
Unfolded proteinMisfolded protein α-glucosidases I & II Unfolded protein Glucose Mannose N-acetylglucosamine α-glucosidase Calnexin/calreticulincycle ERAD Potential antiviral strategies Potential antiviral strategies
N -pentyl idonojirimycin (NP-IDJ) NB-DNJNP-IDJ Glucose geometry Idose geometry
Lys-Lys-Ala-Ala(KKAA) ER retention signal ER retention signal
KKAA CytosolER KKAA ?
N HOOH HO OH N OH OH HO HO N HOOH HO N HOOH HO N-alkylated 7-membered iminosugars Mannosidase inhibitors?
Materials and methods HL60 (human myeloid leukaemia) CGT inhibition Glycosphingolipid analysis Glycosphingolipid analysis RPMI medium RPMI medium + foetal calf serum, + penicillin/streptomycin + L-glutamine 96 h incubation 96 h incubation Initial cell concentration: Initial cell concentration: 2×10 4 cells/ml
Fluorescent labelling with anthralinic acid (2-AA) Fluorescent labelling with anthralinic acid (2-AA) HPLC analysis HPLC analysis Ceramide Glycan Hirudo medicinalis (leech) Ceramide glycanase Extracted with chloroform-methanol Extracted with chloroform-methanol Purified using reverse-phase C18 columns Purified using reverse-phase C18 columns Analysis Materials and methods CGT inhibition
Materials and methods Glucosidase inhibition Free oligosaccharide analysis Free oligosaccharide analysis Misfolded protein Glucose Mannose N-acetylglucosamine PNGase ENGase Mannosidase M5N Lysosome G3M5N Free oligosaccharide (FOS)
NB-DNJ 500 µM Untreated HL60 M5N G1M5N M4N G3M5N Materials and methods Glucosidase inhibition Default pathway for ERAD
Untreated control NP-IDJ 500 µM NB-DNJ 500 µM Results: NP-IDJ NP-IDJ vs. NB-DNJ: HL60 cells FOS profile M5N M4N G3M5N
NP-IDJ 500 µM NP-IDJ 100 µM NP-IDJ 50 µM NP-IDJ 5 µM Results: NP-IDJ NP-IDJ: HL60 cells FOS profile, 24h incubation M5N M4N G3M5N
Results: NP-IDJ NP-IDJ vs. NB-DNJ: HL60 cells FOS profile
Untreated control NP-IDJ 500 µM NB-DNJ 500 µM Results: NP-IDJ NP-IDJ vs. NB-DNJ: HL60 cells GSL profile Lac-Cer GM3 pG Sialyl-pG
Results: NP-IDJ NP-IDJ vs. NB-DNJ: HL60 cells GSL profile
Untreated control KKAA-DNJ 100 µM NB-DNJ 100 µM Results: KKAA-DNJ KKAA-DNJ: HL60 cells FOS profile, 24h incubation G3M5N M5N M4N G1M5N
KKAA-DNJ 100 µM KKAA-DNJ 10 µM KKAA-DNJ 1 µM Results: KKAA-DNJ KKAA-DNJ: HL60 cells FOS profile, 24h incubation M4N M5N G1M5N
Untreated control KKAA-DNJ 100 µM NB-DNJ 100 µM Results: KKAA-DNJ KKAA-DNJ vs. NB-DNJ: HL60 cells FOS profile, 72h incubation M4N M5N G1M5N G3M5N
Results: KKAA-DNJ KKAA-DNJ vs. NB-DNJ: HL60 cells FOS profile, 24h incubation
Results: KKAA-DNJ KKAA-DNJ vs. NB-DNJ: HL60 cells FOS profile, 72h incubation
? Cytosol ER KKAA ? Ceramide-specific glucosyltransferase
Untreated control KKAA-DNJ 200 µM NB-DNJ 200 µM Results: KKAA-DNJ KKAA-DNJ vs. NB-DNJ: HL60 cells GSL profile Lac-Cer GM3 Sialyl-pG pG
Results: KKAA-DNJ KKAA-DNJ vs. NB-DNJ: HL60 cells GSL profile
Results: KKAA-DNJ KKAA-DNJ: in vitro α-glucosidase inhibition IC 50 : 83 µM NB-DNJ IC 50 : 53±16 µM
Results: 7-membered iminosugars 148 vs control: HL60 cells FOS profile Untreated control µM M9N M8N M7N M6N M5N M4N
M9N Kifunensine: mannosidase inhibitor Results: 7-membered iminosugars Untreated control Kifunensine 100 µM
Results: 7-membered iminosugars 149 vs control: HL60 cells FOS profile M9N Untreated control µM
Results: 7-membered iminosugars 266 vs control: HL60 cells FOS profile Untreated control µM
265 vs control: HL60 cells FOS profile Results: 7-membered iminosugars M5N M4N M3N M2N M6N M7N M8N M9N Untreated control µM
OH N OHHO OH OHConclusions NP-IDJ No effect on FOS production No inhibition of α-glucosidases No inhibition of α-glucosidases Significant decrease of GSL levels Effective inhibition of CGT Effective inhibition of CGT Possible therapeutic alternative to NB-DNJ Possible therapeutic alternative to NB-DNJ
Conclusions KKAA-DNJ N OH HO HO OH O KKAA No effect on FOS production Low rates of uptake Low rates of glucosidase inhibition Normal in vitro glucosidase inhibition Low effect on GSL biosynthesis Low rates of CGT inhibition Permeabilization with transfectin?
Strong increase of M2N-M6N concentrations Strong increase of M6N-M9N concentrations Decrease of M4N-M5N concentrations Low or no increase of M7N-M9N concentrations Conclusions N-alkylated 7-membered iminosugars N HOOH HO OH N OH OH HO HO N HOOH HO N HOOH HO No effect
Acknowledgements Dr. Terry Butters Dr. Terry Butters Group Group Oxford university Oxford university St.-Petersburg State University St.-Petersburg State University
St. Mary Le Bow